Chongqing Pharscin Pharmaceutical Co., Ltd. Stock price
Equities
002907
CNE100003308
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.99 CNY | +0.36% | -7.72% | -9.45% |
Sales 2021 | 846M 117M | Sales 2022 | 785M 109M | Capitalization | 8.5B 1.18B |
---|---|---|---|---|---|
Net income 2021 | 91M 12.61M | Net income 2022 | 98M 13.58M | EV / Sales 2021 | 8.26 x |
Net cash position 2021 | 259M 35.94M | Net cash position 2022 | 503M 69.73M | EV / Sales 2022 | 10.2 x |
P/E ratio 2021 |
78.9
x | P/E ratio 2022 |
83.4
x | Employees | 1,416 |
Yield 2021 |
0.28% | Yield 2022 |
0.34% | Free-Float | 18.33% |
1 day | +0.36% | ||
1 week | -7.72% | ||
Current month | +2.79% | ||
1 month | +5.19% | ||
3 months | -8.38% | ||
6 months | -20.06% | ||
Current year | -9.45% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Ying Liu
CEO | Chief Executive Officer | 61 | 15-08-18 |
Kai Yu Xu
CHM | Chairman | 58 | 00-09-30 |
Xiao Yan Peng
DFI | Director of Finance/CFO | 50 | 02-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jia Ming Li
BRD | Director/Board Member | 58 | 22-05-17 |
Hong Tao You
CHM | Chairman | 61 | 15-08-18 |
Xiao Ying Liu
CEO | Chief Executive Officer | 61 | 15-08-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-29 | 14.02 | +0.21% | 1,944,200 |
24-03-28 | 13.99 | +0.36% | 3,697,397 |
24-03-27 | 13.94 | -2.11% | 4,590,245 |
24-03-26 | 14.24 | -0.70% | 3,258,800 |
24-03-25 | 14.34 | -2.38% | 3,164,770 |
End-of-day quote Shenzhen S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.45% | 808M | |
+28.67% | 46.63B | |
+19.30% | 22.49B | |
+20.11% | 14.49B | |
+0.55% | 12.98B | |
+46.16% | 12.16B | |
-2.44% | 7.69B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.80% | 5.15B |